证券代码：688267 证券简称：中触媒 公告编号：2023-032 中触媒新材料股份有限公司 关于收到公司实际控制人、董事长提议 回购公司股份的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 中触媒新材料股份有限公司（以下简称"公司"）于 2023 年 8 月 22 日收到 公司实际控制人、董事长李进先生"关于中触媒新材料股份有限公司回购公司股 份的提议"，提议内容主要如下： 一、提议人提议回购股份的原因和目的 李进先生基于对公司未来发展的信心和对公司价值的高度认可，为建立、完 善公司长效激励机制，充分调动公司员工的积极性，提高团队凝聚力和竞争力， 有效地将股东利益、公司利益和员工利益紧密结合在一起。经综合考虑公司发展 战略、经营情况、财务状况以及未来的盈利能力等因素，提议公司以集中竞价交 易方式回购公司已发行的部分人民币普通股（A 股）股票，并在未来适宜时机全 部用于股权激励或员工持股计划，或用于转换上市公司发行的可转换为股票的公 司债券。 二、提议人的提议内容 1、回购股份的种类：公司发行的人民币普通股（ ...

证券代码：688267 证券简称：中触媒 公告编号：2023-031 中触媒新材料股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次上市流通的限售股份数量为15,853,841股，占中触媒新材料股份有限 公司（以下简称"公司"）总股本的8.9976%，因公司股票发行上市后六个月内连续 20个交易日的收盘价均低于发行价，上述所持有的公司股票的锁定期限自动延长6 个月，限售期为自公司股票上市之日起18个月。 一、本次上市流通的限售股类型 （一）根据中国证券监督管理委员会于2022年1月5日出具的《关于同意中触媒 新材料股份有限公司首次公开发行股票注册的批复》（证监许可[2022]10号），公 司获准向社会公众公开发行人民币普通股（A股）44,050,000股，并于2022年2月16 日在上海证券交易所科创板挂牌上市。本公司首次公开发行A股前总股本为 132,150,000股，首次公开发行A股后公司总股本为176,200,000股。其中有限售条件 流通股139, ...

申万宏源证券承销保荐有限责任公司 关于中触媒新材料股份有限公司 首次公开发行部分限售股上市流通的核查意见 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"或 "保荐机构"）作为中触媒新材料股份有限公司（以下简称"中触媒"、"上市 公司"或"公司"） 首次公开发行股票并在科创板上市的保荐机构，根据《证 券发行上市保荐业务管理办法》、《上海证券交易所科创板股票上市规则》、《上 海证券交易所科创板上市公司自律监管指引第1号——规范运作》、《科创板上 市公司持续监管办法（试行）》等有关法律、法规的规定，对中触媒首次公开发 行部分限售股上市流通事项进行了审慎核查，并出具核查意见如下： 一、本次上市流通的限售股类型 经中国证券监督管理委员会于2022年1月5日出具《关于同意中触媒新材料股 份有限公司首次公开发行股票注册的批复》（证监许可[2022]10号），公司首次 向社会公开发行人民币普通股（A股）44,050,000股，并于2022年2月16日在上海 证券交易所科创板挂牌上市。公司首次公开发行A股前总股本为132,150,000股， 首 次 公 开 发 行 A 股 后 总 股 本 为 176,200,0 ...

证券代码：688267 证券简称：中触媒 公告编号：2023-024 中触媒新材料股份有限公司 （一） 会议召开时间：2023 年 5 月 25 日上午 10:00-11:00 （二）会议召开地点：上证路演中心 关于召开 2022 年度暨 2023 年第一季度业绩说明会 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 中触媒新材料股份有限公司（以下简称"公司"）已于 2023 年 4 月 27 日发 布公司 2022 年年度报告和 2023 年第一季度报告，为便于广大投资者更全面深 入地了解公司 2022 年度和 2023 年第一季度的经营成果、财务状况，公司计划 于 2023 年 5 月 25 日上午 10:00-11:00 举行 2022 年度暨 2023 年第一季度业绩 说明会，就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2022 年度和 2023 年 第一季度的经营成果及财务指标的具体情况与投资者进行互动交流和沟通，在 信息披露允许的范围 ...

Financial Performance - The company's operating revenue for 2022 was CNY 680,662,044.74, representing a 21.37% increase compared to CNY 560,834,783.45 in 2021[21]. - The net profit attributable to shareholders for 2022 was CNY 151,771,550.93, a 13.54% increase from CNY 133,671,641.65 in the previous year[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 1.78% to CNY 126,647,262.98 from CNY 128,936,932.23 in 2021[21]. - The net cash flow from operating activities decreased by 61.58% to CNY 53,248,700.39, primarily due to sales not reaching the collection period[21]. - The total assets at the end of 2022 were CNY 2,994,485,503.03, an increase of 128.80% from CNY 1,308,763,280.58 at the end of 2021[22]. - The net assets attributable to shareholders increased by 216.97% to CNY 2,639,758,728.71 from CNY 832,797,662.16 in the previous year[22]. - Basic earnings per share for 2022 were CNY 0.90, a decrease of 10.89% from CNY 1.01 in 2021[23]. - The gross profit margin for 2022 was 39.64%, with a gross profit of CNY 269,817,719.50[87]. - Operating costs increased by 33.60% to CNY 410,844,325.24, primarily due to rising raw material, energy, and labor costs[86]. Research and Development - The R&D expenditure as a percentage of operating revenue increased to 7.28% from 6.59% in the previous year[23]. - Research and development expenses for 2022 amounted to 49.55 million RMB, representing 7.28% of operating revenue, with a year-on-year increase of 34.03%[34]. - The company has a total of 153 R&D personnel, accounting for 19.22% of the total workforce, with an average salary of RMB 147,594.59[71]. - The total compensation for R&D personnel increased to RMB 22,139,189.19 from RMB 16,158,005.94 in the previous period, reflecting a growth of approximately 36.5%[71]. - The company is actively investing in R&D for new environmentally friendly materials and catalysts, including TRH special molecular sieves and VOCs purification catalysts, to enhance its product matrix[118]. Market Strategy and Expansion - The company plans to continue expanding its domestic and international markets to drive revenue growth[23]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product portfolio[162]. - The company aims to leverage the growing demand for new energy vehicles and green technologies as part of its market expansion strategy[115]. - The company plans to enhance its research and development capabilities in advanced catalytic materials and processes to meet emerging market needs[115]. - The company is focusing on strategic R&D deployment based on market trends, expanding the application of molecular sieves in areas such as adsorption separation and air purification[62]. Corporate Governance - The company’s board of directors and management have confirmed the accuracy and completeness of the annual report[4]. - The company received a standard unqualified audit report from the auditing firm[5]. - There are no special arrangements for corporate governance applicable to the company[8]. - The company has established specialized committees to oversee audit, nomination, compensation, and strategy, ensuring effective management oversight[175]. - The company is committed to transparency and accountability in its financial reporting and governance practices[1]. Risk Management - The company reported no significant risks affecting its operations during the reporting period[4]. - The company has disclosed potential risks related to forward-looking statements in the report[6]. - The company faces customer concentration risk, as BASF is the sole customer for its mobile source denitrification molecular sieve products, which could impact financial stability if demand decreases[79]. - The company emphasizes the importance of maintaining technological advancement to avoid risks associated with core competitiveness, particularly in the energy and chemical sectors[78]. Employee and Compensation - The total number of employees at the end of the reporting period was 796, with 153 in research and development[36]. - The company has established a comprehensive employee training mechanism to enhance professional skills and innovation capabilities[184]. - The company has a strict compensation policy ensuring competitive and fair salaries, adhering to labor laws and regulations[183]. - The total remuneration for all directors, supervisors, and senior management personnel at the end of the reporting period amounted to 8.6286 million RMB[169]. - The total remuneration for core technical personnel at the end of the reporting period was 2.8923 million RMB[169]. Product Development and Innovation - The company focuses on the research, production, and sales of special molecular sieves and catalytic new materials, which are crucial for energy conservation and environmental protection[38]. - The company has developed a series of titanium silicate molecular sieves, which are used as catalysts in the production of important chemical raw materials such as propylene oxide and caprolactam, providing a cost-effective alternative to expensive foreign catalysts[46]. - The company has successfully broken through foreign technical barriers in the production of propylene oxide using the HPPO method, becoming one of the few domestic enterprises with independent technology in this area[47]. - The company has developed core technologies that reduce production costs and improve product quality, including advancements in the preparation of various molecular sieves and catalysts[64]. - The company is working on a new high-silica Y molecular sieve project, with a production capacity of 1,500,000, aimed at VOCs and organic gas adsorption[69]. Financial Management - The company plans to distribute a cash dividend of RMB 2.6 per 10 shares, totaling RMB 45,812,000, which accounts for 30.18% of the net profit attributable to shareholders for 2022[5]. - The company reported a significant increase in financing activities, with net cash flow from financing activities reaching CNY 1,474,532,492.52 due to its initial public offering[86]. - The company confirmed no significant adverse impact from related party transactions[152]. - The company approved a proposal for senior management and core employees to participate in the strategic placement for the initial public offering on the Sci-Tech Innovation Board[171]. - The company is revising internal systems and changing registered capital and company type as part of its strategic adjustments[171].

2023 年第一季度报告 证券代码：688267 证券简称：中触媒 中触媒新材料股份有限公司 2023 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | | 本报告期比上年 | | --- | --- | --- | --- | | | | | 同期增减变动幅 | | | | | 度(%) | | 营业收入 | | 123,407,936.50 | -30.81 | | 归属于上市公司股东的净利润 | | 2,050,387.68 | -93.85 | | 归属于上市公司股东的扣除非 经常性损益的净利润 ...

2022 年第三季度报告 证券代码：688267 证券简称：中触媒 中触媒新材料股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | 年初至报告期末 | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 79,986,787.84 | -27.48 | 408,424,674.23 | -5.71 | | 归属于上市公司股东的 净利 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2022, with total revenue reaching RMB 500 million, representing a 25% year-over-year growth[13]. - The company's operating revenue for the first half of the year was CNY 328.44 million, a 1.72% increase compared to the same period last year[20]. - The company achieved total revenue of CNY 328.44 million in the first half of 2022, an increase of CNY 5.55 million, representing a growth rate of 1.72% compared to the previous year[67]. - The net profit attributable to shareholders decreased by 11.28% to CNY 75.56 million, while the net profit after deducting non-recurring gains and losses fell by 27.43% to CNY 61.14 million[20]. - Net profit for the first half of 2022 was CNY 75,564,634.25, a decrease of 11.29% compared to CNY 85,170,955.23 in the first half of 2021[177]. - Basic earnings per share were CNY 0.47, down 26.56% from the previous year, and the weighted average return on equity was 3.78%, a decrease of 7.31 percentage points[20]. - The company reported a significant increase in sales expenses, which rose to RMB 9.82 million, up 68.67% from RMB 5.84 million in the previous year[180]. - Operating costs increased by 9.07% to CNY 188,775,329.49, primarily due to rising labor costs and natural gas prices[79]. Research and Development - Investment in R&D increased by 30%, totaling RMB 50 million, focusing on the development of new catalyst materials and technologies[13]. - R&D expenses for the first half of 2022 amounted to CNY 22.67 million, accounting for 6.90% of total revenue[68]. - The company is actively investing in R&D for existing products to improve quality and reduce production costs, focusing on denitration molecular sieves and titanium-silicon molecular sieves[30]. - The company has established good R&D cooperation relationships with external units, including research institutions and universities, to enhance innovation capabilities[45]. - R&D investment increased by 32.39% year-on-year, primarily due to the company's ongoing commitment to enhance R&D efforts[52]. - The company has a total of 164 patents, including 121 domestic invention patents and 1 PCT international patent, with 18 patents obtained during the reporting period[50]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2023[13]. - The company has outlined its future outlook, projecting a revenue growth of 20% for the second half of 2022, driven by new product launches and market expansion efforts[13]. - The company is focusing on expanding its product offerings in the catalyst market, particularly in the field of mobile source exhaust denitrification molecular sieves[26]. - The company is actively pursuing market expansion strategies, particularly in the automotive and energy sectors, to leverage new opportunities[58]. - The company aims to enhance its international competitiveness by implementing a "going out" strategy to help quality Chinese enterprises expand in overseas markets[69]. Sustainability and Environmental Commitment - The company remains committed to sustainability initiatives, aiming to reduce carbon emissions by 15% over the next three years[13]. - The company emphasizes environmental protection and sustainable development, with no environmental violations or penalties reported during the reporting period[95][97]. - The company has implemented measures to reduce carbon emissions and improve resource utilization in its industrial processes[98]. Financial Position and Cash Flow - The company's net cash flow from operating activities dropped significantly by 112.61%, resulting in a negative cash flow of CNY -17.35 million[20]. - Cash and cash equivalents at the end of the reporting period were CNY 853,120,621.97, a 1,857.37% increase from CNY 43,585,007.25 at the end of the previous year[80]. - The company has maintained a stable level of fixed assets, which increased to ¥687,852,843.34 from ¥627,809,294.76, reflecting a growth of approximately 9.6%[169]. - The total liabilities decreased to ¥296,300,597.33 from ¥475,965,618.42, showing a reduction of approximately 37.6%[170]. - The company's total equity surged to ¥2,559,052,197.55 from ¥832,797,662.16, representing an increase of about 207%[170]. Risks and Challenges - The management highlighted potential risks, including fluctuations in raw material prices and regulatory changes, which could impact future performance[4]. - The company faces risks related to accounts receivable and inventory management, with significant amounts of accounts receivable and low inventory turnover rates[73]. - The company is subject to increasing environmental protection regulations, which may raise compliance costs and impact operational performance[74]. - The company has experienced short-term adverse effects from the COVID-19 pandemic, but it does not expect long-term impacts on industry growth trends[75]. Shareholder and Governance Commitments - The company has committed to not transferring or entrusting the management of its shares for 36 months following the IPO approval, ensuring stability in shareholding[101]. - The company will limit share reductions to no more than 10% within 24 months after the lock-up period ends, and 20% within the subsequent 24 months[102]. - The company has established strict rules for share reduction to ensure compliance with regulatory requirements and maintain investor confidence[104]. - The company has committed to compensating investors for any losses caused by violations of the commitments made regarding profit distribution[117]. Future Outlook - Future guidance indicates a projected revenue growth of 10% for the next fiscal year, driven by new product launches[196]. - Overall, the financial outlook remains positive, with a commitment to enhancing shareholder value through strategic initiatives[200].

Financial Performance - The company's operating revenue for 2021 was CNY 560,834,783.45, representing a 38.15% increase compared to CNY 405,962,280.30 in 2020[21]. - Net profit attributable to shareholders increased by 45.55% to CNY 133,671,641.65 from CNY 91,839,224.78 in the previous year[22]. - The net cash flow from operating activities surged by 112.16% to CNY 138,610,166.25, up from CNY 65,333,586.69 in 2020[22]. - Basic earnings per share rose to CNY 1.01, a 46.38% increase from CNY 0.69 in the prior year[22]. - The weighted average return on equity improved to 17.20%, an increase of 3.69 percentage points from 13.51% in 2020[22]. - Total assets grew by 4.67% to CNY 1,308,763,280.58, compared to CNY 1,250,411,785.98 at the end of 2020[22]. - The company's net assets attributable to shareholders increased by 14.78% to CNY 832,797,662.16 from CNY 725,580,080.80 in the previous year[22]. - The total profit for 2021 was CNY 151.02 million, an increase of CNY 46.28 million, with a growth rate of 44.18% compared to the previous year[33]. - The company's comprehensive gross margin was 45.17%, up from 44.06% in 2020, indicating a positive trend in profitability[85]. - The company reported a total revenue of 124,281,000.00 RMB, with a year-on-year increase of 44.14%[75]. Research and Development - The company is actively developing new technologies and products, including catalysts for various chemical processes[12]. - Research and development expenses accounted for 6.59% of operating revenue, a slight decrease from 6.94% in 2020[22]. - The company holds a total of 148 patents, including 104 domestic invention patents and 44 utility model patents[34]. - The company plans to enhance its R&D capabilities and management team to support its strategic goals and improve profitability[35]. - R&D investment increased by 31.30% year-on-year, totaling approximately ¥36.97 million, which represents 6.59% of operating revenue[71][72]. - The company has a robust research and development capability, having successfully commercialized titanium-silicon molecular sieve products and other catalysts[81]. - The company has established partnerships with BASF and several domestic research institutions for the development of next-generation denitration molecular sieves[79]. - The company is focusing on the development of new products, including high-performance catalysts for various applications[78]. Market Expansion and Strategy - The company is focused on expanding its market presence in the petrochemical and environmental protection sectors[11]. - The company aims to implement a "go global" strategy to enhance the international competitiveness of Chinese enterprises[35]. - The company is actively expanding its market presence by developing new technologies and products in the field of special molecular sieves and catalysts[35]. - The company has established stable long-term partnerships with international chemical giants like BASF, enhancing its market position[47]. - The company aims to expand its market presence in high-end manufacturing sectors, including aerospace and new energy vehicles[118]. - The company plans to focus on expanding its chemical catalyst product sales and developing new products while ensuring quality improvement[144]. Corporate Governance and Compliance - The company has established a comprehensive internal governance system to strengthen internal controls and protect shareholder rights[36]. - The company has not reported any significant adverse impact from competition with its controlling shareholder[147]. - The board of directors and supervisory board have been re-elected, ensuring continuity in governance[150]. - The company has committed to measures to mitigate the dilution of immediate returns[171]. - The management team emphasized the importance of compliance and governance, particularly in light of recent short-term trading incidents involving board members[165]. Environmental and Social Responsibility - The company actively integrates ESG principles into its daily operations, aiming for sustainable development and social responsibility[192]. - The company adheres to national environmental protection laws and has implemented a circular economy approach, effectively managing waste and promoting resource recycling[193]. - The company has reduced its steam procurement costs since 2020 by transitioning to self-production of steam, emphasizing energy conservation and emission reduction[199]. - The company has implemented effective measures for treating wastewater and air pollutants, ensuring compliance with legal and industry standards[200]. Future Outlook - Future outlook indicates a projected revenue growth of 15% for the next fiscal year, driven by new product launches and market expansion strategies[159]. - The company plans to enhance shareholder value through a proposed dividend increase of 10% in the next fiscal year[166]. - New product lines are expected to launch in Q2 2024, with an estimated contribution of 300 million to the annual revenue[163]. - The company is investing heavily in R&D, with a budget allocation of 1,000 million for the development of new technologies and products in the upcoming year[160].

Financial Performance - The company's operating revenue for Q1 2022 was ¥178,348,581.69, representing a year-on-year increase of 1.89%[5] - The net profit attributable to shareholders decreased by 17.03% to ¥33,342,882.13 compared to the same period last year[5] - Basic and diluted earnings per share were both ¥0.23, down 23.33% year-on-year[6] - Total operating revenue for Q1 2022 was CNY 178,348,581.69, a slight increase of 1.32% compared to CNY 175,044,834.66 in Q1 2021[19] - Net profit for Q1 2022 was CNY 33,342,882.13, a decrease of 17.2% from CNY 40,185,804.98 in Q1 2021[20] - Earnings per share for Q1 2022 were CNY 0.23, down from CNY 0.30 in Q1 2021[21] Assets and Liabilities - Total assets increased by 134.63% to ¥3,070,752,167.12 compared to the end of the previous year[6] - As of March 31, 2022, total assets reached RMB 3,070,752,167.12, a significant increase from RMB 1,308,763,280.58 on December 31, 2021, indicating a growth of approximately 134%[15] - Total liabilities as of Q1 2022 amounted to CNY 486,907,194.32, an increase from CNY 475,965,618.42 in the previous year[18] - The company reported a total current liabilities of RMB 171,755,155.84, up from RMB 152,300,572.00, indicating an increase of around 13%[16] Cash Flow - Cash flow from operating activities was positive, with a notable increase in cash and cash equivalents due to fundraising activities[9] - Cash flow from operating activities in Q1 2022 was CNY 95,845,311.95, a decrease of 34% compared to CNY 145,161,843.65 in Q1 2021[23] - The net cash flow from operating activities was -$9,069,599.77, compared to $53,978,443.63 in the previous period[24] - Total cash inflow from financing activities was $1,739,437,044.93, significantly higher than $31,605,551.66 in the prior period[25] - The net increase in cash and cash equivalents was $1,083,767,029.72, compared to $53,296,309.42 previously[25] - The ending balance of cash and cash equivalents was $1,118,308,259.97, up from $77,376,053.28 previously[25] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 7,871[10] - The largest shareholder, Zhongchumei Group Co., Ltd., held 26.12% of the shares, totaling 46,031,000 shares[11] - The top ten shareholders include major investment funds, with the largest holding being 1,621,001 shares by China Construction Bank[13] Research and Development - The company's R&D investment totaled ¥10,367,002.59, accounting for 5.81% of operating revenue, an increase of 1.05 percentage points[6] - Research and development expenses for Q1 2022 were CNY 10,367,002.59, an increase of 24.5% from CNY 8,330,854.54 in Q1 2021[19] Operational Challenges - The company experienced increased costs in raw materials, energy, and transportation, impacting net profit margins[9] - The company has not disclosed any new product or technology developments during this quarter[14] - There are no significant mergers or acquisitions reported in this quarter[14] - The company has not provided specific future guidance or market expansion strategies in the current report[14]